Diamyd Medical AB Stock: price and insider trades · Sweden

This page follows insider dealings at Diamyd Medical AB as filed with Finansinspektionen, a company from the Health Care sector. In the past year (18 October 2025 to 18 October 2026), 2 filings came from 2 insiders.

Every open-market trade in the period is a purchase: 2 purchases worth €28k, from 2 insiders, and not a single sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. On the buying side, the filings list 2 chief executives among the declarants. Anders Essen-Möller filed the largest purchase, €19k, on 28 April 2026, which represents 0.14% of the company's market value.

Across the 885 companies tracked on its exchange, the median is 7 filings; at 2 filings, this issuer sits below that mark. Over the whole record (from 2025), the tally stands at 3 purchases and no sales.

The last purchase on record was published on 24 June 2026, which is 115 days ago.

Elsewhere in the same sector, our signals recently picked up insider purchases at MAIA Biotechnology, Inc. and Cooper Companies, Inc. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.